Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1977 3
1978 2
1986 2
1987 6
1988 4
1989 3
1990 8
1991 6
1992 2
1993 3
1994 2
1995 3
1996 1
1997 4
1998 2
1999 2
2000 1
2001 1
2003 1
2005 1
2006 2
2009 3
2010 2
2011 2
2012 4
2013 2
2014 1
2015 5
2016 1
2017 2
2018 5
2019 8
2020 7
2021 9
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

110 results
Results by year
Filters applied: . Clear all
Page 1
Disease modification and biomarker development in Parkinson disease: Revision or reconstruction?
Espay AJ, Kalia LV, Gan-Or Z, Williams-Gray CH, Bedard PL, Rowe SM, Morgante F, Fasano A, Stecher B, Kauffman MA, Farrer MJ, Coffey CS, Schwarzschild MA, Sherer T, Postuma RB, Strafella AP, Singleton AB, Barker RA, Kieburtz K, Olanow CW, Lozano A, Kordower JH, Cedarbaum JM, Brundin P, Standaert DG, Lang AE. Espay AJ, et al. Among authors: cedarbaum jm. Neurology. 2020 Mar 17;94(11):481-494. doi: 10.1212/WNL.0000000000009107. Epub 2020 Feb 26. Neurology. 2020. PMID: 32102975 Free PMC article. Review.
Randomized phase I clinical trial of anti-α-synuclein antibody BIIB054.
Brys M, Fanning L, Hung S, Ellenbogen A, Penner N, Yang M, Welch M, Koenig E, David E, Fox T, Makh S, Aldred J, Goodman I, Pepinsky B, Liu Y, Graham D, Weihofen A, Cedarbaum JM. Brys M, et al. Among authors: cedarbaum jm. Mov Disord. 2019 Aug;34(8):1154-1163. doi: 10.1002/mds.27738. Epub 2019 Jun 17. Mov Disord. 2019. PMID: 31211448 Free PMC article. Clinical Trial.
Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression.
Mollenhauer B, Dakna M, Kruse N, Galasko D, Foroud T, Zetterberg H, Schade S, Gera RG, Wang W, Gao F, Frasier M, Chahine LM, Coffey CS, Singleton AB, Simuni T, Weintraub D, Seibyl J, Toga AW, Tanner CM, Kieburtz K, Marek K, Siderowf A, Cedarbaum JM, Hutten SJ, Trenkwalder C, Graham D. Mollenhauer B, et al. Among authors: cedarbaum jm. Mov Disord. 2020 Nov;35(11):1999-2008. doi: 10.1002/mds.28206. Epub 2020 Aug 15. Mov Disord. 2020. PMID: 32798333 Free PMC article.
Seeking progress in disease modification in Parkinson disease.
Lungu C, Cedarbaum JM, Dawson TM, Dorsey ER, Faraco C, Federoff HJ, Fiske B, Fox R, Goldfine AM, Kieburtz K, Macklin EA, Matthews H, Rafaloff G, Saunders-Pullman R, Schor NF, Schwarzschild MA, Sieber BA, Simuni T, Surmeier DJ, Tamiz A, Werner MH, Wright CB, Wyse R. Lungu C, et al. Among authors: cedarbaum jm. Parkinsonism Relat Disord. 2021 Sep;90:134-141. doi: 10.1016/j.parkreldis.2021.09.006. Epub 2021 Sep 10. Parkinsonism Relat Disord. 2021. PMID: 34561166 Review.
Fletcher H. McDowell, MD, 1923-2017.
Cedarbaum JM, Aisen M, Volpe BT. Cedarbaum JM, et al. Ann Neurol. 2017 Jul;82(1):1-3. doi: 10.1002/ana.24959. Epub 2017 Jul 10. Ann Neurol. 2017. PMID: 28544007 No abstract available.
Mutations in GBA and LRRK2 Are Not Associated with Increased Inflammatory Markers.
Thaler A, Omer N, Giladi N, Gurevich T, Bar-Shira A, Gana-Weisz M, Goldstein O, Kestenbaum M, Shirvan JC, Cedarbaum JM, Orr-Urtreger A, Regev K, Shenhar-Tsarfaty S, Mirelman A. Thaler A, et al. Among authors: cedarbaum jm. J Parkinsons Dis. 2021;11(3):1285-1296. doi: 10.3233/JPD-212624. J Parkinsons Dis. 2021. PMID: 33998549 Free PMC article.
Detecting Sensitive Mobility Features for Parkinson's Disease Stages Via Machine Learning.
Mirelman A, Ben Or Frank M, Melamed M, Granovsky L, Nieuwboer A, Rochester L, Del Din S, Avanzino L, Pelosin E, Bloem BR, Della Croce U, Cereatti A, Bonato P, Camicioli R, Ellis T, Hamilton JL, Hass CJ, Almeida QJ, Inbal M, Thaler A, Shirvan J, Cedarbaum JM, Giladi N, Hausdorff JM. Mirelman A, et al. Among authors: cedarbaum jm. Mov Disord. 2021 Sep;36(9):2144-2155. doi: 10.1002/mds.28631. Epub 2021 May 6. Mov Disord. 2021. PMID: 33955603
110 results